DE60320780D1 - Funktionalisierte nanopartikel und verwendungsverfahren - Google Patents

Funktionalisierte nanopartikel und verwendungsverfahren

Info

Publication number
DE60320780D1
DE60320780D1 DE60320780T DE60320780T DE60320780D1 DE 60320780 D1 DE60320780 D1 DE 60320780D1 DE 60320780 T DE60320780 T DE 60320780T DE 60320780 T DE60320780 T DE 60320780T DE 60320780 D1 DE60320780 D1 DE 60320780D1
Authority
DE
Germany
Prior art keywords
use method
functionalized nanoparticles
nucleic acid
acid molecules
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60320780T
Other languages
German (de)
English (en)
Inventor
Weihong Tan
Jin Shouguang
Xiaojun Zhao
Rovelyn Tapec Dytioco
Timothy James Drake
Lisa Renee Hilliard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida
Original Assignee
University of Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida filed Critical University of Florida
Application granted granted Critical
Publication of DE60320780D1 publication Critical patent/DE60320780D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/552—Glass or silica
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/588—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with semiconductor nanocrystal label, e.g. quantum dots

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Silicon Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Powder Metallurgy (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DE60320780T 2002-04-22 2003-04-22 Funktionalisierte nanopartikel und verwendungsverfahren Expired - Lifetime DE60320780D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37512202P 2002-04-22 2002-04-22
US37440502P 2002-04-22 2002-04-22
PCT/US2003/012638 WO2003089906A2 (en) 2002-04-22 2003-04-22 Functionalized nanoparticles and methods of use

Publications (1)

Publication Number Publication Date
DE60320780D1 true DE60320780D1 (de) 2008-06-19

Family

ID=29254555

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60320780T Expired - Lifetime DE60320780D1 (de) 2002-04-22 2003-04-22 Funktionalisierte nanopartikel und verwendungsverfahren

Country Status (10)

Country Link
US (1) US7524630B2 (enExample)
EP (1) EP1499895B1 (enExample)
JP (1) JP4381826B2 (enExample)
CN (1) CN100419426C (enExample)
AT (1) ATE394674T1 (enExample)
AU (1) AU2003234196A1 (enExample)
CA (1) CA2482611A1 (enExample)
DE (1) DE60320780D1 (enExample)
RU (1) RU2004133894A (enExample)
WO (1) WO2003089906A2 (enExample)

Families Citing this family (182)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7192713B1 (en) 1999-05-18 2007-03-20 President And Fellows Of Harvard College Stabilized compounds having secondary structure motifs
CN1312479C (zh) * 2003-08-08 2007-04-25 清华大学 一种纳米荧光磁粒及其制备方法
DK2332968T3 (en) 2003-11-05 2016-08-22 Dana Farber Cancer Inst Inc Alpha-helix peptides suitable for activating or inhibiting cell death
US7906345B2 (en) * 2003-11-12 2011-03-15 The Board Of Trustees Of The Leland Stanford Junior University Magnetic nanoparticles, magnetic detector arrays, and methods for their use in detecting biological molecules
US7462452B2 (en) * 2004-04-30 2008-12-09 Pacific Biosciences Of California, Inc. Field-switch sequencing
AU2005250464B2 (en) * 2004-06-01 2010-10-07 The Penn State Research Foundation Unagglomerated core/shell nanocomposite particles
ES2335115T3 (es) * 2004-06-04 2010-03-22 Basf Se Procedimiento para marcar materiales.
WO2006083305A2 (en) * 2004-06-23 2006-08-10 University Of Texas System Methods and compositions for the detection of biological molecules using a two particle complex
US7405002B2 (en) * 2004-08-04 2008-07-29 Agency For Science, Technology And Research Coated water-soluble nanoparticles comprising semiconductor core and silica coating
US7534489B2 (en) * 2004-09-24 2009-05-19 Agency For Science, Technology And Research Coated composites of magnetic material and quantum dots
WO2007001448A2 (en) 2004-11-04 2007-01-04 Massachusetts Institute Of Technology Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
KR100613189B1 (ko) 2004-11-15 2006-08-21 미지테크주식회사 은 나노 합성 섬유 및 그 제조방법
KR100624447B1 (ko) 2004-11-25 2006-09-18 삼성전자주식회사 은 나노 입자를 이용한 핵산의 정제 방법
US7699979B2 (en) * 2005-01-07 2010-04-20 Board Of Trustees Of The University Of Arkansas Separation system and efficient capture of contaminants using magnetic nanoparticles
US20080135490A1 (en) * 2005-01-07 2008-06-12 Board Of Trustees Of The University Of Arkansas Quantum dot biolabeling and immunomagnetic separation for detection of contaminants
US20060217893A1 (en) * 2005-01-07 2006-09-28 Yanbin Li Method for detecting an unknown contaminant concentration in a substance
US20070055013A1 (en) * 2005-02-21 2007-03-08 Noriho Kamiya Substrate and method of immobilizing protein
WO2006094198A2 (en) 2005-03-03 2006-09-08 University Of North Dakota Surfaces coated with target-induced fluorescent compounds for detection of target elements
CN1861628B (zh) * 2005-05-11 2010-05-05 上海师范大学 一种分离中药蛋白质的方法
KR101111747B1 (ko) * 2005-05-16 2012-06-12 삼성엘이디 주식회사 혼합 나노 입자 및 이를 이용한 전자소자
US20100063263A1 (en) 2005-06-23 2010-03-11 Siemens Medical Solutions Diagnostics Gmbh Magnetic particles with a closed ultrathin silica layer, method for the production thereof and their use
US20110097277A1 (en) 2005-08-25 2011-04-28 University Of Washington Particles coated with zwitterionic polymers
EP1934609A4 (en) * 2005-09-08 2009-06-24 Biterials Co Ltd MAGNETIC NANOPARTICLE WITH FLUORESCENCE AND MANUFACTURING METHOD AND USE THEREOF
US8906609B1 (en) 2005-09-26 2014-12-09 Arrowhead Center, Inc. Label-free biomolecule sensor based on surface charge modulated ionic conductance
CN101321686A (zh) * 2005-10-07 2008-12-10 佛罗里达大学研究基金会有限公司 用于多路信号传递和光编码的多组分纳米颗粒
CN100441677C (zh) * 2005-10-20 2008-12-10 上海师范大学 免疫磁性纳米粒子细菌分离器及其制法和应用
KR100886084B1 (ko) * 2005-12-06 2009-02-26 주식회사 엘지화학 코어-쉘 형태의 나노입자 및 그 제조방법
US20090317802A1 (en) * 2005-12-09 2009-12-24 Bhatia Sangeeta N Compositions and Methods to Monitor RNA Delivery to Cells
WO2007075456A2 (en) * 2005-12-15 2007-07-05 University Of Florida Research Foundation, Inc. Colorimetric light switching probe for ultrasensitive detection of target compounds
US9267937B2 (en) 2005-12-15 2016-02-23 Massachusetts Institute Of Technology System for screening particles
CN100371713C (zh) * 2006-01-13 2008-02-27 东南大学 金或银纳米粒子的表面功能化及比色检测生物分子的方法
JP4670659B2 (ja) * 2006-01-25 2011-04-13 住友電気工業株式会社 蛍光標識金属粉末、ならびに該蛍光標識金属粉末を含有する異方導電膜、実装品
FR2898519B1 (fr) * 2006-03-20 2009-01-09 Commissariat Energie Atomique Nanoparticules notamment a structure coeur coquilles, enrobees
CA2648099C (en) * 2006-03-31 2012-05-29 The Brigham And Women's Hospital, Inc System for targeted delivery of therapeutic agents
US8367113B2 (en) 2006-05-15 2013-02-05 Massachusetts Institute Of Technology Polymers for functional particles
US9381477B2 (en) 2006-06-23 2016-07-05 Massachusetts Institute Of Technology Microfluidic synthesis of organic nanoparticles
EP1889810A1 (en) * 2006-08-10 2008-02-20 HeiQ Materials AG Method for producing nanoparticle loaded powders using flame spray pyrolysis and applications thereof
US20100120016A1 (en) * 2006-09-01 2010-05-13 Yanbin Li Methods and systems for detection of contaminants
CN1987454B (zh) * 2006-10-31 2011-01-12 成都夸常医学工业有限公司 含定向纳米结构功能化区的纳米结构组成及其制备和应用方法
WO2008147456A2 (en) * 2006-11-20 2008-12-04 Massachusetts Institute Of Technology Drug delivery systems using fc fragments
EP2093194B1 (en) * 2006-12-01 2012-03-21 National University Corporation Shimane University Fluorescent labeling agent and fluorescent labeling method
US20080213377A1 (en) * 2006-12-08 2008-09-04 Bhatia Sangeeta N Delivery of Nanoparticles and/or Agents to Cells
MX2009007101A (es) 2006-12-29 2009-12-01 Univ Washington Superficies y materiales antibioincrustación bifuncionales.
PL2118123T3 (pl) 2007-01-31 2016-06-30 Dana Farber Cancer Inst Inc Stabilizowane peptydy p53 i ich zastosowania
US9217129B2 (en) * 2007-02-09 2015-12-22 Massachusetts Institute Of Technology Oscillating cell culture bioreactor
KR101525754B1 (ko) 2007-03-28 2015-06-09 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 스티칭된 폴리펩티드
WO2008124634A1 (en) 2007-04-04 2008-10-16 Massachusetts Institute Of Technology Polymer-encapsulated reverse micelles
JP2010523595A (ja) 2007-04-04 2010-07-15 マサチューセッツ インスティテュート オブ テクノロジー ポリ（アミノ酸）ターゲッティング部分
US8239008B2 (en) * 2007-04-13 2012-08-07 Ethicon Endo-Surgery, Inc. Sentinel node identification using fluorescent nanoparticles
EP2140264A1 (en) * 2007-04-19 2010-01-06 3M Innovative Properties Company Methods of use of solid support material for binding biomolecules
CN101663581A (zh) * 2007-04-19 2010-03-03 3M创新有限公司 水分散性二氧化硅纳米颗粒在连接生物分子方面的用途
JP4981510B2 (ja) * 2007-04-27 2012-07-25 古河電気工業株式会社 逆ミセル分散系を用いてなるシリカナノ粒子の製造方法、該方法により得られたシリカナノ粒子、及びそれを用いた標識試薬
DE102007020220B3 (de) 2007-04-28 2008-11-13 Forschungszentrum Karlsruhe Gmbh Verfahren zur magnetisch unterstützten Extraktion
US20080269086A1 (en) * 2007-04-30 2008-10-30 Atanu Adhvaryu Functionalized nanosphere lubricants
WO2009015359A2 (en) * 2007-07-26 2009-01-29 Cellay, Llc Highly visible chromosome-specific probes and related methods
EP2025364A1 (en) * 2007-08-13 2009-02-18 Procter & Gamble International Operations SA. Compositions comprising dye-loaded particles
EP2062946B1 (en) * 2007-08-13 2012-06-06 Procter & Gamble International Operations SA Dye-loaded particles
ATE491001T1 (de) * 2007-08-13 2010-12-15 Procter & Gamble Internat Operations Sa Sprühtrocknungsverfahren zur herstellung farbstoffhaltiger teilchen
US20090047222A1 (en) * 2007-08-15 2009-02-19 Ben Gu Color Stable Peroxide Containing Dentifrice Formulations With Dye Encapsulated Silica Shell Nanoparticles
JP5192752B2 (ja) * 2007-08-15 2013-05-08 古河電気工業株式会社 逆ミセル分散系を用いてなるシリカナノ粒子の製造方法、該方法により得られたシリカナノ粒子、及びそれを用いた標識試薬
CA2917512C (en) 2007-10-12 2025-08-05 President And Fellows Of Harvard College VACCINE NANOTECHNOLOGY
US9533006B2 (en) 2007-11-19 2017-01-03 University Of Washington Marine coatings
WO2009126249A1 (en) 2008-04-11 2009-10-15 Board Of Regents Of The University Of Texas System Method and apparatus for nanoparticle electrogenerated chemiluminescence amplification
EP2626693A3 (en) 2008-05-08 2014-10-01 Board of Regents of the University of Texas System Luminescent nanostructured materials for use in electrogenerated chemiluminescence
JP2009275006A (ja) * 2008-05-16 2009-11-26 Univ Of Tokyo 低酸素環境測定用試薬
WO2010011313A2 (en) 2008-07-23 2010-01-28 President And Fellows Of Harvard College Ligation of stapled polypeptides
WO2010014222A1 (en) * 2008-07-30 2010-02-04 Dana-Farber Cancer Institute, Inc. Compositions for detecting cell death and methods of use thereof
CN102203126A (zh) * 2008-09-22 2011-09-28 爱勒让治疗公司 用于制备纯化的多肽组合物的方法
US8343497B2 (en) 2008-10-12 2013-01-01 The Brigham And Women's Hospital, Inc. Targeting of antigen presenting cells with immunonanotherapeutics
US8343498B2 (en) 2008-10-12 2013-01-01 Massachusetts Institute Of Technology Adjuvant incorporation in immunonanotherapeutics
US8591905B2 (en) * 2008-10-12 2013-11-26 The Brigham And Women's Hospital, Inc. Nicotine immunonanotherapeutics
US8277812B2 (en) * 2008-10-12 2012-10-02 Massachusetts Institute Of Technology Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
US8512417B2 (en) 2008-11-14 2013-08-20 Dune Sciences, Inc. Functionalized nanoparticles and methods of forming and using same
US10080578B2 (en) 2008-12-16 2018-09-25 Nico Corporation Tissue removal device with adjustable delivery sleeve for neurosurgical and spinal surgery applications
CN101444503B (zh) * 2008-12-31 2011-02-02 江苏大学 一种水飞蓟宾高效长效制剂及其制法
CN101439025B (zh) * 2008-12-31 2011-05-11 江苏大学 一种水飞蓟素高效长效制剂及其制法
EP2376100B1 (en) 2009-01-14 2017-10-25 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
JP5717720B2 (ja) 2009-04-15 2015-05-13 コーネル ユニバーシティＣｏｒｎｅｌｌ Ｕｎｉｖｅｒｓｉｔｙ シリカの高密度化で改良された蛍光シリカナノ粒子
WO2010138193A2 (en) 2009-05-27 2010-12-02 Selecta Biosciences, Inc. Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents
WO2010147859A1 (en) * 2009-06-15 2010-12-23 William Marsh Rice University Nanomaterial-containing signaling compositions for assay of flowing liquid streams and geological formations and methods for use thereof
US9377449B2 (en) 2009-06-15 2016-06-28 William Marsh Rice University Nanocomposite oil sensors for downhole hydrocarbon detection
WO2011008260A2 (en) 2009-07-13 2011-01-20 President And Fellows Of Harvard College Bifunctional stapled polypeptides and uses thereof
CN102712675A (zh) 2009-09-22 2012-10-03 爱勒让治疗公司 拟肽大环化合物
US8715150B2 (en) 2009-11-02 2014-05-06 Pulse Therapeutics, Inc. Devices for controlling magnetic nanoparticles to treat fluid obstructions
WO2011057224A2 (en) 2009-11-06 2011-05-12 University Of Washington Through Its Center For Commercialization Zwitterionic polymer bioconjugates and related methods
CN102192986B (zh) * 2010-03-19 2014-06-11 成都盛泰尔生物医药科技有限公司 一种心肌肌钙蛋白i的检测试剂
JP5503382B2 (ja) * 2010-04-05 2014-05-28 古河電気工業株式会社 イムノクロマトグラフィー用複合粒子
US20120015344A1 (en) * 2010-05-14 2012-01-19 1. Board of Trustees of MICHIGAN STATE UNIVERSITY Methods, compositions, and apparatus for the detection of viral strains
WO2011150264A2 (en) 2010-05-26 2011-12-01 Selecta Biosciences, Inc. Synthetic nanocarrier combination vaccines
US8975232B2 (en) 2010-07-29 2015-03-10 President And Fellows Of Harvard College Macrocyclic kinase inhibitors and uses thereof
US9121065B2 (en) 2010-08-09 2015-09-01 The Trustees Of The University Of Pennsylvania Nanoparticle-oligonucleotide hybrid structures and methods of use thereof
CA2807685C (en) 2010-08-13 2020-10-06 Aileron Therapeutics, Inc. P53 derived peptidomimetic macrocycle
WO2012040459A2 (en) 2010-09-22 2012-03-29 President And Fellows Of Harvard College Beta-catenin targeting peptides and uses thereof
JP6157352B2 (ja) 2010-10-08 2017-07-05 シティ・オブ・ホープＣｉｔｙ ｏｆ Ｈｏｐｅ メディトープ（Ｍｅｄｉｔｏｐｅ）のためのモノクローナル抗体フレームワーク結合インターフェース、メディトープ送達系、およびその使用法
US8962804B2 (en) 2010-10-08 2015-02-24 City Of Hope Meditopes and meditope-binding antibodies and uses thereof
US8992985B2 (en) 2010-11-05 2015-03-31 Massachusetts Institute Of Technology Core-shell magnetic particles and related methods
GB201019434D0 (en) * 2010-11-17 2010-12-29 Isis Innovation Sonosensitive nanoparticles
WO2012111686A1 (ja) * 2011-02-15 2012-08-23 協和メデックス株式会社 ストレプトアビジン結合磁性粒子の製造方法
JPWO2012111687A1 (ja) * 2011-02-15 2014-07-07 協和メデックス株式会社 ストレプトアビジン結合磁性粒子の製造方法
WO2012111685A1 (ja) * 2011-02-15 2012-08-23 協和メデックス株式会社 ストレプトアビジン結合磁性粒子及びその製造方法
US8916696B2 (en) 2011-06-12 2014-12-23 City Of Hope Aptamer-mRNA conjugates for targeted protein or peptide expression and methods for their use
US9487562B2 (en) 2011-06-17 2016-11-08 President And Fellows Of Harvard College Stabilized polypeptides as regulators of RAB GTPase function
JP6023192B2 (ja) 2011-07-01 2016-11-09 プレジデント アンド フェローズ オブ ハーバード カレッジ 大環状インスリン分解酵素（ｉｄｅ）阻害剤およびその使用
CA2843274A1 (en) 2011-07-29 2013-02-07 Selecta Biosciences, Inc. Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses
MX355877B (es) 2011-09-30 2018-05-03 Dana Farber Cancer Inst Inc Peptidos terapeuticos.
CN104039809A (zh) 2011-10-10 2014-09-10 希望之城公司 中间位和中间位结合抗体及其用途
TW201806968A (zh) 2011-10-18 2018-03-01 艾利倫治療公司 擬肽巨環化合物
US10077290B2 (en) 2011-12-29 2018-09-18 Dana-Farber Cancer Institute, Inc. Stabilized antiviral fusion helices
KR20130084091A (ko) 2012-01-16 2013-07-24 삼성전자주식회사 화상형성장치
US10031138B2 (en) 2012-01-20 2018-07-24 University Of Washington Through Its Center For Commercialization Hierarchical films having ultra low fouling and high recognition element loading properties
SG11201404728VA (en) * 2012-02-10 2014-09-26 Lockheed Corp Nanoparticle paste formulations and methods for production and use thereof
US9428553B2 (en) 2012-02-10 2016-08-30 City Of Hope Meditopes and meditope-binding antibodies and uses thereof
BR112014020103A2 (pt) 2012-02-15 2018-10-09 Aileron Therapeutics, Inc. macrociclos peptidomiméticos
CA2864120A1 (en) 2012-02-15 2013-08-22 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
CN102618257B (zh) * 2012-03-09 2014-01-29 浙江大学 一种上转换荧光纳米材料的表面包覆方法
CA2870288A1 (en) 2012-04-10 2013-10-17 John J. Rossi Rna aptamers for therapeutic and diagnostic delivery to pancreatic cancer cells
EP3443916A3 (en) 2012-05-15 2019-04-24 Pulse Therapeutics, Inc. Magnetic-based systems
US9883878B2 (en) 2012-05-15 2018-02-06 Pulse Therapeutics, Inc. Magnetic-based systems and methods for manipulation of magnetic particles
CN102786030B (zh) * 2012-07-06 2014-03-12 江苏大学 一种通过溶剂处理制备多肽纳米薄膜的方法
KR101543583B1 (ko) * 2012-08-24 2015-08-11 단국대학교 산학협력단 생체 분자 분석용 미소 입자 및 키트와 생체 분자 분석용 미소 입자의 제조 방법
RS61957B1 (sr) 2012-09-26 2021-07-30 Harvard College Uvezani peptidi blokirani prolinom i njihove upotrebe
US20150225471A1 (en) 2012-10-01 2015-08-13 President And Fellows Of Harvard College Stabilized polypeptide insulin receptor modulators
WO2014065753A1 (en) * 2012-10-23 2014-05-01 Dso National Laboratories Direct visual detection of nucleic acid using gold nanoparticles
KR20150082307A (ko) 2012-11-01 2015-07-15 에일러론 테라퓨틱스 인코포레이티드 이치환 아미노산 및 이의 제조 및 사용 방법
WO2014107449A1 (en) * 2013-01-01 2014-07-10 The Trustees Of Columbia University In The City Of New York Molecule structure probe methods, devices, and systems
WO2014116813A1 (en) * 2013-01-25 2014-07-31 Douglas Scientific Silica-based biological material isolation
WO2014130488A1 (en) * 2013-02-19 2014-08-28 University Of Massachusetts Functionalized nanoparticles for medical treatments
EP3782638A1 (en) 2013-03-13 2021-02-24 President and Fellows of Harvard College Stapled and stitched polypeptides and uses thereof
US10308926B2 (en) 2013-03-15 2019-06-04 Dana-Farber Cancer Institute, Inc. Stablized EZH2 peptides
US10745483B2 (en) 2013-03-15 2020-08-18 Dana-Farber Cancer Institute, Inc. Therapeutic peptides
US10087215B2 (en) 2013-03-15 2018-10-02 Dana-Farber Cancer Institute, Inc. Stabilized SOS1 peptides
US10106590B2 (en) 2013-03-15 2018-10-23 Dana-Farber Cancer Institute, Inc. BH4 stabilized peptides and uses thereof
US10227390B2 (en) 2013-06-14 2019-03-12 President And Fellows Of Harvard College Stabilized polypeptide insulin receptor modulators
US9409148B2 (en) 2013-08-08 2016-08-09 Uchicago Argonne, Llc Compositions and methods for direct capture of organic materials from process streams
KR101660399B1 (ko) * 2013-08-23 2016-09-28 주식회사 메디센서 금 나노 입자를 포함하는 형광 입자 및 그 제조방법
WO2015034469A2 (en) * 2013-09-03 2015-03-12 Aneeve Nanotechnologies, Llc A process for cleaning carbon nanotubes and other nanostructured films
RU2670512C2 (ru) * 2013-09-23 2018-10-23 Ренссилэйер Политекник Инститьют Доставка генов, опосредованная наночастицами, геномная коррекция и лиганд-направленная модификация в различных клеточных популяциях
WO2015048527A1 (en) 2013-09-27 2015-04-02 Tufts University Optically transparent silk hydrogels
US10925999B2 (en) 2013-10-08 2021-02-23 Trustees Of Tufts College Tunable covalently crosslinked hydrogels and methods of making the same
WO2015054493A1 (en) * 2013-10-09 2015-04-16 Nanocomposix, Inc. Encapsulated particles
WO2015070108A1 (en) 2013-11-08 2015-05-14 Tufts University Peptide-based nanofibrillar materials
US10106611B2 (en) 2013-12-06 2018-10-23 Dana-Farber Cancer Institute, Inc. Antibodies that bind to MHC class I polypeptide-related sequence A
JP6681334B2 (ja) * 2013-12-31 2020-04-15 メモリアル スローン ケタリング キャンサー センター リアルタイムの蛍光源のマルチチャネル撮像のためのシステム、方法、および装置
JP2017510631A (ja) 2014-03-14 2017-04-13 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド 癌に対しｎｋｇ２ｄ経路機能を回復させるためのワクチン組成物および方法
JP6156229B2 (ja) * 2014-03-31 2017-07-05 株式会社Ｊｖｃケンウッド 粒子の製造方法
JP6759109B2 (ja) 2014-05-21 2020-09-23 プレジデント アンド フェローズ オブ ハーバード カレッジ Ｒａｓ抑制性ペプチドおよびその使用
CN106457196B (zh) * 2014-05-23 2019-04-26 株式会社岛津制作所 磁性物质颗粒的操作方法和磁性物质颗粒操作用装置
JP6734011B2 (ja) * 2014-06-06 2020-08-05 古河電気工業株式会社 生体分子検出用試験キット、及びこれを用いた生体分子の検出方法、並びにこれらに用いられる生体分子検出用試験片及び生体分子検出用標識試薬
US10174363B2 (en) 2015-05-20 2019-01-08 Quantum-Si Incorporated Methods for nucleic acid sequencing
SG10201902598VA (en) 2014-09-24 2019-04-29 Aileron Therapeutics Inc Peptidomimetic macrocycles and formulations thereof
MX2017003797A (es) 2014-09-24 2017-06-15 Aileron Therapeutics Inc Macrociclos peptidomimeticos y usos de los mismos.
CN106999587B (zh) 2014-10-02 2023-09-29 希望之城公司 多价中间表位，中间表位结合抗体及其用途
JP6182520B2 (ja) * 2014-12-01 2017-08-16 三洋化成工業株式会社 磁性シリカ粒子、該磁性シリカ粒子を用いた測定対象物質測定方法及び測定対象物質測定用試薬
FR3031063B1 (fr) * 2014-12-30 2017-02-10 Biomerieux Sa Complexe multicouches, procede de fabrication et utilisation du complexe
CA2979507A1 (en) 2015-03-12 2016-09-15 Tufts University Shape memory silk materials
CA2979999A1 (en) 2015-03-18 2016-09-22 Massachusetts Institute Of Technology Selective mcl-1 binding peptides
US10253067B2 (en) 2015-03-20 2019-04-09 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
WO2016172631A2 (en) 2015-04-24 2016-10-27 President And Fellows Of Harvard College Substrate selective inhibitors of insulin-degrading enzyme (ide) and uses thereof
KR101646610B1 (ko) * 2015-05-28 2016-08-09 (주)바이오니아 생체 물질 정제용 고활성 실리카 자성나노입자 및 이의 제조 방법
CN107735684A (zh) * 2015-06-26 2018-02-23 柯尼卡美能达美国研究所有限公司 快速且高敏感的细菌检测
WO2017004548A1 (en) 2015-07-01 2017-01-05 Aileron Therapeutics, Inc. Peptidomimetic macrocycles
CN108025082A (zh) 2015-07-28 2018-05-11 塔夫茨大学信托人 多肽整料
WO2017023527A1 (en) 2015-08-03 2017-02-09 Advanced Endovascular Therapeutics Novel coatings for medical devices
CN108368161A (zh) 2015-09-10 2018-08-03 艾瑞朗医疗公司 作为mcl-1调节剂的拟肽大环化合物
WO2017059338A1 (en) 2015-10-02 2017-04-06 Cornell University Enzyme-responsive peptide nanofiber compositions and uses thereof
WO2017123383A2 (en) 2015-12-17 2017-07-20 Trustees Of Tufts College Silk-fibroin hydrogels, methods of forming, and uses thereof
US11198715B2 (en) 2016-07-22 2021-12-14 Massachusetts Institute Of Technology Selective Bfl-1 peptides
WO2018026853A1 (en) 2016-08-01 2018-02-08 Trustees Of Tufts College Biomimetic mechanical tension driven fabrication of nanofibrillar architecture
JP7069126B2 (ja) 2016-08-26 2022-05-17 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド 化学療法誘発性末梢性ニューロパシーおよび難聴を処置または予防するためのｂｃｌ－ｗポリペプチドおよび模倣物
US10369167B2 (en) 2016-11-01 2019-08-06 City Of Hope Continuously expressed therapeutic RNAs for targeted protein binding and methods for their use
WO2018112282A1 (en) 2016-12-14 2018-06-21 Ligandal, Inc. Compositions and methods for nucleic acid and/or protein payload delivery
CA3080871C (en) * 2017-10-31 2024-05-28 F. Hoffmann-La Roche Ag Improved magnetic beads comprising a liquid-glass coating and uses thereof in nucleic acid capture or purification
WO2019123156A1 (en) * 2017-12-19 2019-06-27 3M Innovative Properties Company Compositions and methods to detect microorganisms
US11674136B2 (en) 2018-02-09 2023-06-13 President And Fellows Of Harvard College DNA-templated macrocycle library
US11918315B2 (en) 2018-05-03 2024-03-05 Pulse Therapeutics, Inc. Determination of structure and traversal of occlusions using magnetic particles
WO2020060975A1 (en) 2018-09-17 2020-03-26 Massachusetts Institute Of Technology Peptides selective for bcl-2 family proteins
CA3113568A1 (en) * 2018-10-01 2020-04-09 Kemira Oyj A method for determining concentration of polyelectrolytes and phosphonates
CN109444406A (zh) * 2018-11-09 2019-03-08 深圳市众循精准医学研究院 定量检测标志物cyfra21-1的试纸条及其制备方法和检测方法
CN109521194B (zh) * 2018-11-30 2023-03-31 暨南大学 DNA免疫吸附剂在制备抗ds-DNA抗体检测试剂中的应用
CN110878336B (zh) * 2019-11-18 2022-06-14 大连理工大学 一种基于Fe3O4@C纳米颗粒的miRNA光学传感检测方法
US20230355811A1 (en) * 2020-09-28 2023-11-09 University Of Florida Research Foundation, Inc. Compositions including magnetic nanoparticles and methods of using and making the same
US12171443B1 (en) 2021-03-09 2024-12-24 Pulse Therapeutics, Inc. Magnetically controlled flow generation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4297337A (en) * 1979-04-13 1981-10-27 Corning Glass Works Solid-phase immunoassays using magnetic glass
US4661408A (en) * 1986-03-18 1987-04-28 E.I. Du Pont De Nemours And Company Coated chromium dioxide particles
US5091206A (en) * 1987-10-26 1992-02-25 Baxter Diagnostics Inc. Process for producing magnetically responsive polymer particles and application thereof
DE69527877T2 (de) * 1994-04-29 2003-04-30 Seradyn, Inc. Mikropartikel-Immunoassayreagentien, empfindliche und spezifische Immunoassayreagentien und Immunoassaymethode
DE69636553T2 (de) * 1995-07-07 2007-05-31 Toyo Boseki K.K. Nukleinsäuren bindender magnetischer Träger und Verfahren für die Nukleinsäureisolierung unter dessen Verwendung
AU7685498A (en) * 1997-05-14 1998-12-08 Weixin Tang Fully-coated, uniform-sized metallic particles
US5990479A (en) 1997-11-25 1999-11-23 Regents Of The University Of California Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes
US6251303B1 (en) 1998-09-18 2001-06-26 Massachusetts Institute Of Technology Water-soluble fluorescent nanocrystals
CA2384429A1 (en) * 1999-09-14 2001-03-22 Michael K. Bahr Magnetic nanoparticles having biochemical activity, method for the production thereof and their use
CA2403708A1 (en) * 2000-03-22 2001-09-27 Quantum Dot Corporation Methods of using semiconductor nanocrystals in bead-based nucleic acid assays
US6548264B1 (en) * 2000-05-17 2003-04-15 University Of Florida Coated nanoparticles

Also Published As

Publication number Publication date
RU2004133894A (ru) 2005-04-20
JP2005523027A (ja) 2005-08-04
EP1499895A2 (en) 2005-01-26
CN1662815A (zh) 2005-08-31
EP1499895B1 (en) 2008-05-07
EP1499895A4 (en) 2005-08-10
CA2482611A1 (en) 2003-10-30
CN100419426C (zh) 2008-09-17
AU2003234196A8 (en) 2003-11-03
AU2003234196A1 (en) 2003-11-03
WO2003089906A2 (en) 2003-10-30
JP4381826B2 (ja) 2009-12-09
US20040067503A1 (en) 2004-04-08
US7524630B2 (en) 2009-04-28
WO2003089906A3 (en) 2004-01-22
ATE394674T1 (de) 2008-05-15
HK1075698A1 (en) 2005-12-23

Similar Documents

Publication Publication Date Title
DE60320780D1 (de) Funktionalisierte nanopartikel und verwendungsverfahren
WO2004092331A3 (en) Composition and method for nucleic acid sequencing
MY136437A (en) Methods and apparatus for nucleic acid sequencing by signal stretching and data intergration
ATE330038T1 (de) Nukleinsäure-biosensor
WO2004058990A3 (en) Genetic polymorphisms associated with stenosis, methods of detection and uses thereof
EP2500440A3 (en) Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
DK2725107T3 (da) DNA-sekventering med ikke-fluorescerende nukleotidreversible terminatorer og ddNTP'er modificeret med spaltbart mærke og nukleinsyre omfattende inosin med reversible terminatorer
EP2521796A4 (en) DNA SEQUENCING METHODS AND DETECTORS AND SYSTEMS FOR THEIR IMPLEMENTATION
WO2001092572A1 (en) Kit and method for determining hla type
GEP20125384B (en) Representations of nucleotide sequences
ATE551349T1 (de) Methode unter verwendung von reversibel blockierten markierungsoligonukleotiden
WO2004081186A3 (en) Single nucleotide polymorphisms associated with stenosis, methods of detection and uses thereof
NZ600183A (en) Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means
EP2366803A3 (en) Compositions and methods for detecting west nile virus
MX9705961A (es) Polimerasa de adn termoestable, modificada.
Liu et al. Binding induced isothermal amplification reaction to activate CRISPR/Cas12a for amplified electrochemiluminescence detection of rabies viral RNA via DNA nanotweezer structure switching
EP1784512A4 (en) ELECTROCATALYTIC NUCLEIC ACID HYBRIDIZATION DETECTION
Song et al. Trypsin-amplified aerolysin nanopore amplified sandwich assay for attomolar nucleic acid and single bacteria detection
Hong et al. DNA–gold nanoparticles network based electrochemical biosensors for DNA MTase activity
WO2005087953A3 (en) Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
Chen et al. Enzymatic polymerization-based formation of fluorescent copper nanoparticles for the nuclease assay
Dongare et al. High-throughput sequencing: A breakthrough in molecular diagnosis for precision medicine
TW200506067A (en) Method of detecting target nucleotide sequence, detection target structure to be used in embodying the method, process for producing the same and assay kit for detecting target nucleotide sequence
ATE445715T1 (de) Elektrokatalytischer nukleinsäurehybridisierungsnachweis
EP3040423A3 (en) Microrna and uses thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition